[5] Originally formed in 1980 in Amsterdam as a subsidiary of NMB Bank, now part of ING Group, Atlas historically invested in both life sciences and information technology startup companies.

[6][7] Previously as a diversified firm, Atlas had raised over $3.0 billion of investor commitments across nine venture capital funds.

In 2017, Atlas Venture announced it had raised Fund XI at $350 million in capital to invest in early stage biotech companies in the U.S. and around the world.

[13] In January 2019, Atlas Venture announced its Opportunity Fund I raised $250 million.

[14] In June 2020, Atlas Venture announced its Fund XII raised $400 million.